Literature DB >> 7643916

Suramin analogs, divalent cations and ATP gamma S as inhibitors of ecto-ATPase.

M W Beukers1, C J Kerkhof, M A van Rhee, U Ardanuy, C Gurgel, H Widjaja, P Nickel, A P IJzerman, W Soudijn.   

Abstract

Ecto-nucleotidases are plasma membrane-bound enzymes that sequentially dephosphorylate extracellular nucleotides such as ATP. This breakdown of ATP and other nucleotides obscures the characterization and classification of P2 (nucleotide) receptors. We therefore studied suramin and several of its analogs, divalent cations and ATP gamma S for their ability to inhibit ecto-ATPase in human blood cells. Suramin itself and Ni2+ were the more potent, non-competitive inhibitors with micromolar affinity. ATP gamma S also displayed micromolar affinity and inhibited ecto-ATPase competitively. The data obtained with the divalent cations demonstrate that coordination of the phosphate chain but not the N7 of the adenine ring is required for the breakdown of ATP by ecto-ATPase. Divalent cations that coordinate both the phosphate chain and N7 inhibit ecto-ATPase in a non-competitive manner.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7643916     DOI: 10.1007/bf00171044

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  16 in total

1.  The effect of arsenate on aerobic phosphorylation.

Authors:  R K CRANE; F LIPMANN
Journal:  J Biol Chem       Date:  1953-03       Impact factor: 5.157

2.  Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery.

Authors:  P Leff; B E Wood; S E O'Connor
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

Review 3.  Extracellular ATP: effects, sources and fate.

Authors:  J L Gordon
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

Review 4.  Recent research on the biological activity of suramin.

Authors:  T E Voogd; E L Vansterkenburg; J Wilting; L H Janssen
Journal:  Pharmacol Rev       Date:  1993-06       Impact factor: 25.468

5.  The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladder.

Authors:  S M Hourani; J A Chown
Journal:  Gen Pharmacol       Date:  1989

6.  Increases in intracellular calcium via activation of an endogenous P2-purinoceptor in cultured CHO-K1 cells.

Authors:  P A Iredale; S J Hill
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

7.  [Potential filaricides. Suramin analogs].

Authors:  P Nickel; H J Haack; H Widjaja; U Ardanuy; C Gurgel; D Düwel; H Loewe; W Raether
Journal:  Arzneimittelforschung       Date:  1986-08

8.  Characterization of ecto-ATPase on human blood cells. A physiological role in platelet aggregation?

Authors:  M W Beukers; I M Pirovano; A van Weert; C J Kerkhof; A P IJzerman; W Soudijn
Journal:  Biochem Pharmacol       Date:  1993-12-03       Impact factor: 5.858

9.  Characterization of ecto-nucleoside triphosphatase on A-431 human epidermoidal carcinoma cells.

Authors:  K Kurihara; K Hosoi; T Ueha
Journal:  Enzyme       Date:  1992

10.  Purification and characterization of a Ca2+/Mg2+ ecto-ATPase from rat heart sarcolemma.

Authors:  B S Tuana; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1988-05       Impact factor: 3.396

View more
  9 in total

1.  A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreaction.

Authors:  Jamshed Iqbal; Petra Vollmayer; Norbert Braun; Herbert Zimmermann; Christa E Müller
Journal:  Purinergic Signal       Date:  2005-12-03       Impact factor: 3.765

2.  Diadenosine polyphosphate hydrolase from presynaptic plasma membranes of Torpedo electric organ.

Authors:  J Mateo; P Rotllan; E Marti; I Gomez De Aranda; C Solsona; M T Miras-Portugal
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

3.  Suramin--a powerful inhibitor of neural ecto-diadenosine polyphosphate hydrolase.

Authors:  J Mateo; P Rotllán; M T Miras-Portugal
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

4.  P2-purinoceptor antagonists: I. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphonates.

Authors:  R Bültmann; B Pause; H Wittenburg; G Kurz; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

5.  P2-purinoceptor antagonists: III. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin.

Authors:  R Bültmann; H Wittenburg; B Pause; G Kurz; P Nickel; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

6.  Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages.

Authors:  B C Chen; C M Lee; W W Lin
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

7.  ATP Inhibits Breast Cancer Migration and Bone Metastasis through Down-Regulation of CXCR4 and Purinergic Receptor P2Y11.

Authors:  Xiaowen Liu; Manuel A Riquelme; Yi Tian; Dezhi Zhao; Francisca M Acosta; Sumin Gu; Jean X Jiang
Journal:  Cancers (Basel)       Date:  2021-08-26       Impact factor: 6.575

8.  Action of suramin upon ecto-apyrase activity and synaptic depression of Torpedo electric organ.

Authors:  E Martí; C Cantí; I Gómez de Aranda; F Miralles; C Solsona
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

9.  Adenosine-containing molecules amplify glucose signaling and enhance txnip expression.

Authors:  Fa-Xing Yu; Shuang-Ru Goh; Ru-Ping Dai; Yan Luo
Journal:  Mol Endocrinol       Date:  2009-02-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.